Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs UNICHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA UNICHEM LAB ASTRAZENECA PHARMA/
UNICHEM LAB
 
P/E (TTM) x 95.5 236.1 40.5% View Chart
P/BV x 22.7 1.4 1,598.9% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
UNICHEM LAB
Mar-23
ASTRAZENECA PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs3,620467 775.1%   
Low Rs2,438226 1,078.7%   
Sales per share (Unadj.) Rs401.2190.7 210.3%  
Earnings per share (Unadj.) Rs39.7-28.7 -138.3%  
Cash flow per share (Unadj.) Rs46.2-12.6 -366.5%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.4344.2 68.1%  
Shares outstanding (eoy) m25.0070.41 35.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.8 415.6%   
Avg P/E ratio x76.3-12.1 -632.2%  
P/CF ratio (eoy) x65.5-27.5 -238.5%  
Price / Book Value ratio x12.91.0 1,283.2%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,71824,396 310.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5913,564 72.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03013,430 74.7%  
Other income Rs m261385 67.8%   
Total revenues Rs m10,29113,815 74.5%   
Gross profit Rs m1,249-841 -148.5%  
Depreciation Rs m1631,134 14.3%   
Interest Rs m6173 3.6%   
Profit before tax Rs m1,341-1,764 -76.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348259 134.6%   
Profit after tax Rs m993-2,022 -49.1%  
Gross profit margin %12.5-6.3 -198.8%  
Effective tax rate %26.0-14.7 -177.0%   
Net profit margin %9.9-15.1 -65.7%  
BALANCE SHEET DATA
Current assets Rs m9,35915,885 58.9%   
Current liabilities Rs m4,8446,396 75.7%   
Net working cap to sales %45.070.7 63.7%  
Current ratio x1.92.5 77.8%  
Inventory Days Days4951 96.6%  
Debtors Days Days391,600 2.4%  
Net fixed assets Rs m2,06115,911 13.0%   
Share capital Rs m50141 35.5%   
"Free" reserves Rs m5,81124,092 24.1%   
Net worth Rs m5,86124,233 24.2%   
Long term debt Rs m0636 0.0%   
Total assets Rs m11,42131,829 35.9%  
Interest coverage x213.9-9.2 -2,327.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.4 208.1%   
Return on assets %8.7-5.8 -150.6%  
Return on equity %16.9-8.3 -203.0%  
Return on capital %23.0-6.4 -359.4%  
Exports to sales %069.7 0.0%   
Imports to sales %37.412.4 300.7%   
Exports (fob) Rs mNA9,366 0.0%   
Imports (cif) Rs m3,7471,669 224.6%   
Fx inflow Rs m6129,366 6.5%   
Fx outflow Rs m3,7471,669 224.6%   
Net fx Rs m-3,1357,697 -40.7%   
CASH FLOW
From Operations Rs m583-851 -68.5%  
From Investments Rs m1812,028 8.9%  
From Financial Activity Rs m-245-813 30.1%  
Net Cashflow Rs m519746 69.6%  

Share Holding

Indian Promoters % 0.0 70.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 11.3 47.9%  
FIIs % 2.7 0.8 316.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 29.8 83.9%  
Shareholders   29,032 20,877 139.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Unichem Lab

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Unichem Lab Share Price Performance

Period ASTRAZENECA PHARMA Unichem Lab S&P BSE HEALTHCARE
1-Day 0.01% 1.90% 1.18%
1-Month -3.61% -5.40% -0.75%
1-Year 59.20% 78.12% 61.82%
3-Year CAGR 20.50% 16.06% 18.16%
5-Year CAGR 22.18% 19.87% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Unichem Lab share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Unichem Lab the stake stands at 70.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Unichem Lab.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Unichem Lab paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Unichem Lab.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.